Global Pezolerocept Market Growth 2026-2032
The global Pezolerocept market size is predicted to grow from US$ 83.15 million in 2025 to US$ 445 million in 2032; it is expected to grow at a CAGR of 12.9% from 2026 to 2032.
Spesolimab is a humanized monoclonal antibody targeting the interleukin-36 receptor (IL-36R), a targeted immunological biologic agent. It specifically binds to and blocks the IL-36 receptor signaling pathway to suppress excessive inflammatory responses in the skin and related tissues. Primarily indicated for the treatment of autoinflammatory skin diseases such as generalized pustular psoriasis, it represents a precision-targeted therapy against the pathogenesis of pustular psoriasis, characterized by rapid onset and high specificity in clinical practice.In 2025, global Spesolimab production reached approximately 18,000?22,000 vials
Spesolimab, the world?s first IL-36 receptor-targeted biologic exclusively developed for generalized pustular psoriasis (GPP), holds a first-in-class monopoly in the global rare dermatology market by addressing a long-standing unmet medical need with its precise mechanism that blocks the core inflammatory pathway and rapidly controls life-threatening symptoms. Approved in over 40 countries and regions worldwide, its global commercialization has been fully transferred to LEO Pharma, which leverages its specialized dermatology platform and global network to enhance disease awareness and treatment access. Positioned as a high-value orphan drug, it adopts a premium pricing strategy supported by strong clinical evidence; despite a limited patient population, it benefits from a clear competitive landscape with no direct same-target competitors, and its long-term growth hinges on indication expansion, approval of subcutaneous maintenance therapy, and broader insurance coverage. Characterized by a niche but essential market, specialty-driven promotion, global footprint, and indication-led expansion, spesolimab is poised to unlock broader potential in IL-36-mediated autoinflammatory skin disorders as research and clinical adoption advance.
LP Information, Inc. (LPI) ' newest research report, the ?Pezolerocept Industry Forecast? looks at past sales and reviews total world Pezolerocept sales in 2025, providing a comprehensive analysis by region and market sector of projected Pezolerocept sales for 2026 through 2032. With Pezolerocept sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pezolerocept industry.
This Insight Report provides a comprehensive analysis of the global Pezolerocept landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pezolerocept portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pezolerocept market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pezolerocept and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pezolerocept.
This report presents a comprehensive overview, market shares, and growth opportunities of Pezolerocept market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pezolerocept market?
What factors are driving Pezolerocept market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pezolerocept market opportunities vary by end market size?
How does Pezolerocept break out by Type, by Application?
Spesolimab is a humanized monoclonal antibody targeting the interleukin-36 receptor (IL-36R), a targeted immunological biologic agent. It specifically binds to and blocks the IL-36 receptor signaling pathway to suppress excessive inflammatory responses in the skin and related tissues. Primarily indicated for the treatment of autoinflammatory skin diseases such as generalized pustular psoriasis, it represents a precision-targeted therapy against the pathogenesis of pustular psoriasis, characterized by rapid onset and high specificity in clinical practice.In 2025, global Spesolimab production reached approximately 18,000?22,000 vials
Spesolimab, the world?s first IL-36 receptor-targeted biologic exclusively developed for generalized pustular psoriasis (GPP), holds a first-in-class monopoly in the global rare dermatology market by addressing a long-standing unmet medical need with its precise mechanism that blocks the core inflammatory pathway and rapidly controls life-threatening symptoms. Approved in over 40 countries and regions worldwide, its global commercialization has been fully transferred to LEO Pharma, which leverages its specialized dermatology platform and global network to enhance disease awareness and treatment access. Positioned as a high-value orphan drug, it adopts a premium pricing strategy supported by strong clinical evidence; despite a limited patient population, it benefits from a clear competitive landscape with no direct same-target competitors, and its long-term growth hinges on indication expansion, approval of subcutaneous maintenance therapy, and broader insurance coverage. Characterized by a niche but essential market, specialty-driven promotion, global footprint, and indication-led expansion, spesolimab is poised to unlock broader potential in IL-36-mediated autoinflammatory skin disorders as research and clinical adoption advance.
LP Information, Inc. (LPI) ' newest research report, the ?Pezolerocept Industry Forecast? looks at past sales and reviews total world Pezolerocept sales in 2025, providing a comprehensive analysis by region and market sector of projected Pezolerocept sales for 2026 through 2032. With Pezolerocept sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pezolerocept industry.
This Insight Report provides a comprehensive analysis of the global Pezolerocept landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pezolerocept portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pezolerocept market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pezolerocept and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pezolerocept.
This report presents a comprehensive overview, market shares, and growth opportunities of Pezolerocept market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 450 mg/7.5 mL
- 150 mg/mL
- Intravenous Infusion
- Subcutaneous Injection
- Combined With Conventional Immunosuppressive Agents
- Combined With Topical Glucocorticoids
- Hospital
- Retail
- Online
- Treatment Of Generalized Pustular Psoriasis
- Treatment Of Palmoplantar Pustulosis
- Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
What is the 10-year outlook for the global Pezolerocept market?
What factors are driving Pezolerocept market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pezolerocept market opportunities vary by end market size?
How does Pezolerocept break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pezolerocept Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pezolerocept by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pezolerocept by Country/Region, 2021, 2025 & 2032
2.2 Pezolerocept Segment by Type
2.2.1 450 mg/7.5 mL
2.2.2 150 mg/mL
2.2.3 Pezolerocept Sales by Type
2.2.3.1 Global Pezolerocept Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pezolerocept Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pezolerocept Sale Price by Type (2021-2026)
2.3 Pezolerocept Segment by Route of Administration
2.3.1 Intravenous Infusion
2.3.2 Subcutaneous Injection
2.3.3 Pezolerocept Sales by Route of Administration
2.3.3.1 Global Pezolerocept Sales Market Share by Route of Administration (2021-2026)
2.3.3.2 Global Pezolerocept Revenue and Market Share by Route of Administration (2021-2026)
2.3.3.3 Global Pezolerocept Sale Price by Route of Administration (2021-2026)
2.4 Pezolerocept Segment by Combination Therapy
2.4.1 Combined With Conventional Immunosuppressive Agents
2.4.2 Combined With Topical Glucocorticoids
2.4.3 Pezolerocept Sales by Combination Therapy
2.4.3.1 Global Pezolerocept Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Pezolerocept Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Pezolerocept Sale Price by Combination Therapy (2021-2026)
2.5 Pezolerocept Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Pezolerocept Sales by Sales Channels
2.5.4.1 Global Pezolerocept Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Pezolerocept Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Pezolerocept Sale Price by Sales Channels (2021-2026)
2.6 Pezolerocept Segment by Application
2.6.1 Treatment Of Generalized Pustular Psoriasis
2.6.2 Treatment Of Palmoplantar Pustulosis
2.6.3 Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases
2.6.4 Others
2.6.5 Pezolerocept Sales by Application
2.6.5.1 Global Pezolerocept Sale Market Share by Application (2021-2026)
2.6.5.2 Global Pezolerocept Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Pezolerocept Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pezolerocept Breakdown Data by Company
3.1.1 Global Pezolerocept Annual Sales by Company (2021-2026)
3.1.2 Global Pezolerocept Sales Market Share by Company (2021-2026)
3.2 Global Pezolerocept Annual Revenue by Company (2021-2026)
3.2.1 Global Pezolerocept Revenue by Company (2021-2026)
3.2.2 Global Pezolerocept Revenue Market Share by Company (2021-2026)
3.3 Global Pezolerocept Sale Price by Company
3.4 Key Manufacturers Pezolerocept Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pezolerocept Product Location Distribution
3.4.2 Players Pezolerocept Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEZOLEROCEPT BY GEOGRAPHIC REGION
4.1 World Historic Pezolerocept Market Size by Geographic Region (2021-2026)
4.1.1 Global Pezolerocept Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pezolerocept Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pezolerocept Market Size by Country/Region (2021-2026)
4.2.1 Global Pezolerocept Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pezolerocept Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pezolerocept Sales Growth
4.4 APAC Pezolerocept Sales Growth
4.5 Europe Pezolerocept Sales Growth
4.6 Middle East & Africa Pezolerocept Sales Growth
5 AMERICAS
5.1 Americas Pezolerocept Sales by Country
5.1.1 Americas Pezolerocept Sales by Country (2021-2026)
5.1.2 Americas Pezolerocept Revenue by Country (2021-2026)
5.2 Americas Pezolerocept Sales by Type (2021-2026)
5.3 Americas Pezolerocept Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pezolerocept Sales by Region
6.1.1 APAC Pezolerocept Sales by Region (2021-2026)
6.1.2 APAC Pezolerocept Revenue by Region (2021-2026)
6.2 APAC Pezolerocept Sales by Type (2021-2026)
6.3 APAC Pezolerocept Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pezolerocept by Country
7.1.1 Europe Pezolerocept Sales by Country (2021-2026)
7.1.2 Europe Pezolerocept Revenue by Country (2021-2026)
7.2 Europe Pezolerocept Sales by Type (2021-2026)
7.3 Europe Pezolerocept Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pezolerocept by Country
8.1.1 Middle East & Africa Pezolerocept Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pezolerocept Revenue by Country (2021-2026)
8.2 Middle East & Africa Pezolerocept Sales by Type (2021-2026)
8.3 Middle East & Africa Pezolerocept Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pezolerocept
10.3 Manufacturing Process Analysis of Pezolerocept
10.4 Industry Chain Structure of Pezolerocept
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pezolerocept Distributors
11.3 Pezolerocept Customer
12 WORLD FORECAST REVIEW FOR PEZOLEROCEPT BY GEOGRAPHIC REGION
12.1 Global Pezolerocept Market Size Forecast by Region
12.1.1 Global Pezolerocept Forecast by Region (2027-2032)
12.1.2 Global Pezolerocept Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pezolerocept Forecast by Type (2027-2032)
12.7 Global Pezolerocept Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pezolerocept Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pezolerocept Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pezolerocept Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pezolerocept by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pezolerocept by Country/Region, 2021, 2025 & 2032
2.2 Pezolerocept Segment by Type
2.2.1 450 mg/7.5 mL
2.2.2 150 mg/mL
2.2.3 Pezolerocept Sales by Type
2.2.3.1 Global Pezolerocept Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pezolerocept Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pezolerocept Sale Price by Type (2021-2026)
2.3 Pezolerocept Segment by Route of Administration
2.3.1 Intravenous Infusion
2.3.2 Subcutaneous Injection
2.3.3 Pezolerocept Sales by Route of Administration
2.3.3.1 Global Pezolerocept Sales Market Share by Route of Administration (2021-2026)
2.3.3.2 Global Pezolerocept Revenue and Market Share by Route of Administration (2021-2026)
2.3.3.3 Global Pezolerocept Sale Price by Route of Administration (2021-2026)
2.4 Pezolerocept Segment by Combination Therapy
2.4.1 Combined With Conventional Immunosuppressive Agents
2.4.2 Combined With Topical Glucocorticoids
2.4.3 Pezolerocept Sales by Combination Therapy
2.4.3.1 Global Pezolerocept Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Pezolerocept Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Pezolerocept Sale Price by Combination Therapy (2021-2026)
2.5 Pezolerocept Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Pezolerocept Sales by Sales Channels
2.5.4.1 Global Pezolerocept Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Pezolerocept Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Pezolerocept Sale Price by Sales Channels (2021-2026)
2.6 Pezolerocept Segment by Application
2.6.1 Treatment Of Generalized Pustular Psoriasis
2.6.2 Treatment Of Palmoplantar Pustulosis
2.6.3 Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases
2.6.4 Others
2.6.5 Pezolerocept Sales by Application
2.6.5.1 Global Pezolerocept Sale Market Share by Application (2021-2026)
2.6.5.2 Global Pezolerocept Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Pezolerocept Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pezolerocept Breakdown Data by Company
3.1.1 Global Pezolerocept Annual Sales by Company (2021-2026)
3.1.2 Global Pezolerocept Sales Market Share by Company (2021-2026)
3.2 Global Pezolerocept Annual Revenue by Company (2021-2026)
3.2.1 Global Pezolerocept Revenue by Company (2021-2026)
3.2.2 Global Pezolerocept Revenue Market Share by Company (2021-2026)
3.3 Global Pezolerocept Sale Price by Company
3.4 Key Manufacturers Pezolerocept Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pezolerocept Product Location Distribution
3.4.2 Players Pezolerocept Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEZOLEROCEPT BY GEOGRAPHIC REGION
4.1 World Historic Pezolerocept Market Size by Geographic Region (2021-2026)
4.1.1 Global Pezolerocept Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pezolerocept Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pezolerocept Market Size by Country/Region (2021-2026)
4.2.1 Global Pezolerocept Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pezolerocept Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pezolerocept Sales Growth
4.4 APAC Pezolerocept Sales Growth
4.5 Europe Pezolerocept Sales Growth
4.6 Middle East & Africa Pezolerocept Sales Growth
5 AMERICAS
5.1 Americas Pezolerocept Sales by Country
5.1.1 Americas Pezolerocept Sales by Country (2021-2026)
5.1.2 Americas Pezolerocept Revenue by Country (2021-2026)
5.2 Americas Pezolerocept Sales by Type (2021-2026)
5.3 Americas Pezolerocept Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pezolerocept Sales by Region
6.1.1 APAC Pezolerocept Sales by Region (2021-2026)
6.1.2 APAC Pezolerocept Revenue by Region (2021-2026)
6.2 APAC Pezolerocept Sales by Type (2021-2026)
6.3 APAC Pezolerocept Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pezolerocept by Country
7.1.1 Europe Pezolerocept Sales by Country (2021-2026)
7.1.2 Europe Pezolerocept Revenue by Country (2021-2026)
7.2 Europe Pezolerocept Sales by Type (2021-2026)
7.3 Europe Pezolerocept Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pezolerocept by Country
8.1.1 Middle East & Africa Pezolerocept Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pezolerocept Revenue by Country (2021-2026)
8.2 Middle East & Africa Pezolerocept Sales by Type (2021-2026)
8.3 Middle East & Africa Pezolerocept Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pezolerocept
10.3 Manufacturing Process Analysis of Pezolerocept
10.4 Industry Chain Structure of Pezolerocept
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pezolerocept Distributors
11.3 Pezolerocept Customer
12 WORLD FORECAST REVIEW FOR PEZOLEROCEPT BY GEOGRAPHIC REGION
12.1 Global Pezolerocept Market Size Forecast by Region
12.1.1 Global Pezolerocept Forecast by Region (2027-2032)
12.1.2 Global Pezolerocept Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pezolerocept Forecast by Type (2027-2032)
12.7 Global Pezolerocept Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pezolerocept Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pezolerocept Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pezolerocept Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pezolerocept Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 450 mg/7.5 mL
Table 4. Major Players of 150 mg/mL
Table 5. Global Pezolerocept Sales by Type (2021-2026) & (Units)
Table 6. Global Pezolerocept Sales Market Share by Type (2021-2026)
Table 7. Global Pezolerocept Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pezolerocept Revenue Market Share by Type (2021-2026)
Table 9. Global Pezolerocept Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Intravenous Infusion
Table 11. Major Players of Subcutaneous Injection
Table 12. Global Pezolerocept Sales by Route of Administration (2021-2026) & (Units)
Table 13. Global Pezolerocept Sales Market Share by Route of Administration (2021-2026)
Table 14. Global Pezolerocept Revenue by Route of Administration (2021-2026) & ($ million)
Table 15. Global Pezolerocept Revenue Market Share by Route of Administration (2021-2026)
Table 16. Global Pezolerocept Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 17. Major Players of Combined With Conventional Immunosuppressive Agents
Table 18. Major Players of Combined With Topical Glucocorticoids
Table 19. Global Pezolerocept Sales by Combination Therapy (2021-2026) & (Units)
Table 20. Global Pezolerocept Sales Market Share by Combination Therapy (2021-2026)
Table 21. Global Pezolerocept Revenue by Combination Therapy (2021-2026) & ($ million)
Table 22. Global Pezolerocept Revenue Market Share by Combination Therapy (2021-2026)
Table 23. Global Pezolerocept Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Pezolerocept Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Pezolerocept Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Pezolerocept Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Pezolerocept Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Pezolerocept Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Pezolerocept Sale by Application (2021-2026) & (Units)
Table 33. Global Pezolerocept Sale Market Share by Application (2021-2026)
Table 34. Global Pezolerocept Revenue by Application (2021-2026) & ($ million)
Table 35. Global Pezolerocept Revenue Market Share by Application (2021-2026)
Table 36. Global Pezolerocept Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Pezolerocept Sales by Company (2021-2026) & (Units)
Table 38. Global Pezolerocept Sales Market Share by Company (2021-2026)
Table 39. Global Pezolerocept Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Pezolerocept Revenue Market Share by Company (2021-2026)
Table 41. Global Pezolerocept Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Pezolerocept Producing Area Distribution and Sales Area
Table 43. Players Pezolerocept Products Offered
Table 44. Pezolerocept Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Pezolerocept Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Pezolerocept Sales Market Share Geographic Region (2021-2026)
Table 49. Global Pezolerocept Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Pezolerocept Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Pezolerocept Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Pezolerocept Sales Market Share by Country/Region (2021-2026)
Table 53. Global Pezolerocept Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Pezolerocept Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Pezolerocept Sales by Country (2021-2026) & (Units)
Table 56. Americas Pezolerocept Sales Market Share by Country (2021-2026)
Table 57. Americas Pezolerocept Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Pezolerocept Sales by Type (2021-2026) & (Units)
Table 59. Americas Pezolerocept Sales by Application (2021-2026) & (Units)
Table 60. APAC Pezolerocept Sales by Region (2021-2026) & (Units)
Table 61. APAC Pezolerocept Sales Market Share by Region (2021-2026)
Table 62. APAC Pezolerocept Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Pezolerocept Sales by Type (2021-2026) & (Units)
Table 64. APAC Pezolerocept Sales by Application (2021-2026) & (Units)
Table 65. Europe Pezolerocept Sales by Country (2021-2026) & (Units)
Table 66. Europe Pezolerocept Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Pezolerocept Sales by Type (2021-2026) & (Units)
Table 68. Europe Pezolerocept Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Pezolerocept Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Pezolerocept Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Pezolerocept Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Pezolerocept Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Pezolerocept
Table 74. Key Market Challenges & Risks of Pezolerocept
Table 75. Key Industry Trends of Pezolerocept
Table 76. Pezolerocept Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Pezolerocept Distributors List
Table 79. Pezolerocept Customer List
Table 80. Global Pezolerocept Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Pezolerocept Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Pezolerocept Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Pezolerocept Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Pezolerocept Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Pezolerocept Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Pezolerocept Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Pezolerocept Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Pezolerocept Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Pezolerocept Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Pezolerocept Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Boehringer Ingelheim Basic Information, Pezolerocept Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Pezolerocept Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Pezolerocept Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
Table 1. Pezolerocept Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pezolerocept Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 450 mg/7.5 mL
Table 4. Major Players of 150 mg/mL
Table 5. Global Pezolerocept Sales by Type (2021-2026) & (Units)
Table 6. Global Pezolerocept Sales Market Share by Type (2021-2026)
Table 7. Global Pezolerocept Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pezolerocept Revenue Market Share by Type (2021-2026)
Table 9. Global Pezolerocept Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Intravenous Infusion
Table 11. Major Players of Subcutaneous Injection
Table 12. Global Pezolerocept Sales by Route of Administration (2021-2026) & (Units)
Table 13. Global Pezolerocept Sales Market Share by Route of Administration (2021-2026)
Table 14. Global Pezolerocept Revenue by Route of Administration (2021-2026) & ($ million)
Table 15. Global Pezolerocept Revenue Market Share by Route of Administration (2021-2026)
Table 16. Global Pezolerocept Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 17. Major Players of Combined With Conventional Immunosuppressive Agents
Table 18. Major Players of Combined With Topical Glucocorticoids
Table 19. Global Pezolerocept Sales by Combination Therapy (2021-2026) & (Units)
Table 20. Global Pezolerocept Sales Market Share by Combination Therapy (2021-2026)
Table 21. Global Pezolerocept Revenue by Combination Therapy (2021-2026) & ($ million)
Table 22. Global Pezolerocept Revenue Market Share by Combination Therapy (2021-2026)
Table 23. Global Pezolerocept Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Pezolerocept Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Pezolerocept Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Pezolerocept Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Pezolerocept Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Pezolerocept Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Pezolerocept Sale by Application (2021-2026) & (Units)
Table 33. Global Pezolerocept Sale Market Share by Application (2021-2026)
Table 34. Global Pezolerocept Revenue by Application (2021-2026) & ($ million)
Table 35. Global Pezolerocept Revenue Market Share by Application (2021-2026)
Table 36. Global Pezolerocept Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Pezolerocept Sales by Company (2021-2026) & (Units)
Table 38. Global Pezolerocept Sales Market Share by Company (2021-2026)
Table 39. Global Pezolerocept Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Pezolerocept Revenue Market Share by Company (2021-2026)
Table 41. Global Pezolerocept Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Pezolerocept Producing Area Distribution and Sales Area
Table 43. Players Pezolerocept Products Offered
Table 44. Pezolerocept Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Pezolerocept Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Pezolerocept Sales Market Share Geographic Region (2021-2026)
Table 49. Global Pezolerocept Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Pezolerocept Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Pezolerocept Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Pezolerocept Sales Market Share by Country/Region (2021-2026)
Table 53. Global Pezolerocept Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Pezolerocept Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Pezolerocept Sales by Country (2021-2026) & (Units)
Table 56. Americas Pezolerocept Sales Market Share by Country (2021-2026)
Table 57. Americas Pezolerocept Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Pezolerocept Sales by Type (2021-2026) & (Units)
Table 59. Americas Pezolerocept Sales by Application (2021-2026) & (Units)
Table 60. APAC Pezolerocept Sales by Region (2021-2026) & (Units)
Table 61. APAC Pezolerocept Sales Market Share by Region (2021-2026)
Table 62. APAC Pezolerocept Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Pezolerocept Sales by Type (2021-2026) & (Units)
Table 64. APAC Pezolerocept Sales by Application (2021-2026) & (Units)
Table 65. Europe Pezolerocept Sales by Country (2021-2026) & (Units)
Table 66. Europe Pezolerocept Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Pezolerocept Sales by Type (2021-2026) & (Units)
Table 68. Europe Pezolerocept Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Pezolerocept Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Pezolerocept Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Pezolerocept Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Pezolerocept Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Pezolerocept
Table 74. Key Market Challenges & Risks of Pezolerocept
Table 75. Key Industry Trends of Pezolerocept
Table 76. Pezolerocept Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Pezolerocept Distributors List
Table 79. Pezolerocept Customer List
Table 80. Global Pezolerocept Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Pezolerocept Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Pezolerocept Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Pezolerocept Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Pezolerocept Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Pezolerocept Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Pezolerocept Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Pezolerocept Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Pezolerocept Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Pezolerocept Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Pezolerocept Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Pezolerocept Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Boehringer Ingelheim Basic Information, Pezolerocept Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Pezolerocept Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Pezolerocept Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pezolerocept
Figure 2. Pezolerocept Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pezolerocept Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Pezolerocept Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pezolerocept Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pezolerocept Sales Market Share by Country/Region (2025)
Figure 10. Pezolerocept Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 450 mg/7.5 mL
Figure 12. Product Picture of 150 mg/mL
Figure 13. Global Pezolerocept Sales Market Share by Type in 2026
Figure 14. Global Pezolerocept Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Intravenous Infusion
Figure 16. Product Picture of Subcutaneous Injection
Figure 17. Global Pezolerocept Sales Market Share by Route of Administration in 2026
Figure 18. Global Pezolerocept Revenue Market Share by Route of Administration (2021-2026)
Figure 19. Product Picture of Combined With Conventional Immunosuppressive Agents
Figure 20. Product Picture of Combined With Topical Glucocorticoids
Figure 21. Global Pezolerocept Sales Market Share by Combination Therapy in 2026
Figure 22. Global Pezolerocept Revenue Market Share by Combination Therapy (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Pezolerocept Sales Market Share by Sales Channels in 2026
Figure 27. Global Pezolerocept Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Pezolerocept Consumed in Treatment Of Generalized Pustular Psoriasis
Figure 29. Global Pezolerocept Market: Treatment Of Generalized Pustular Psoriasis (2021-2026) & (Units)
Figure 30. Pezolerocept Consumed in Treatment Of Palmoplantar Pustulosis
Figure 31. Global Pezolerocept Market: Treatment Of Palmoplantar Pustulosis (2021-2026) & (Units)
Figure 32. Pezolerocept Consumed in Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases
Figure 33. Global Pezolerocept Market: Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases (2021-2026) & (Units)
Figure 34. Pezolerocept Consumed in Others
Figure 35. Global Pezolerocept Market: Others (2021-2026) & (Units)
Figure 36. Global Pezolerocept Sale Market Share by Application (2025)
Figure 37. Global Pezolerocept Revenue Market Share by Application in 2025
Figure 38. Pezolerocept Sales by Company in 2025 (Units)
Figure 39. Global Pezolerocept Sales Market Share by Company in 2025
Figure 40. Pezolerocept Revenue by Company in 2025 ($ millions)
Figure 41. Global Pezolerocept Revenue Market Share by Company in 2025
Figure 42. Global Pezolerocept Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Pezolerocept Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Pezolerocept Sales 2021-2026 (Units)
Figure 45. Americas Pezolerocept Revenue 2021-2026 ($ millions)
Figure 46. APAC Pezolerocept Sales 2021-2026 (Units)
Figure 47. APAC Pezolerocept Revenue 2021-2026 ($ millions)
Figure 48. Europe Pezolerocept Sales 2021-2026 (Units)
Figure 49. Europe Pezolerocept Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Pezolerocept Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Pezolerocept Revenue 2021-2026 ($ millions)
Figure 52. Americas Pezolerocept Sales Market Share by Country in 2025
Figure 53. Americas Pezolerocept Revenue Market Share by Country (2021-2026)
Figure 54. Americas Pezolerocept Sales Market Share by Type (2021-2026)
Figure 55. Americas Pezolerocept Sales Market Share by Application (2021-2026)
Figure 56. United States Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Pezolerocept Sales Market Share by Region in 2025
Figure 61. APAC Pezolerocept Revenue Market Share by Region (2021-2026)
Figure 62. APAC Pezolerocept Sales Market Share by Type (2021-2026)
Figure 63. APAC Pezolerocept Sales Market Share by Application (2021-2026)
Figure 64. China Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 68. India Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Pezolerocept Sales Market Share by Country in 2025
Figure 72. Europe Pezolerocept Revenue Market Share by Country (2021-2026)
Figure 73. Europe Pezolerocept Sales Market Share by Type (2021-2026)
Figure 74. Europe Pezolerocept Sales Market Share by Application (2021-2026)
Figure 75. Germany Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 76. France Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Pezolerocept Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Pezolerocept Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Pezolerocept Sales Market Share by Application (2021-2026)
Figure 83. Egypt Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Pezolerocept in 2026
Figure 89. Manufacturing Process Analysis of Pezolerocept
Figure 90. Industry Chain Structure of Pezolerocept
Figure 91. Channels of Distribution
Figure 92. Global Pezolerocept Sales Market Forecast by Region (2027-2032)
Figure 93. Global Pezolerocept Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Pezolerocept Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Pezolerocept Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Pezolerocept Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Pezolerocept Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pezolerocept
Figure 2. Pezolerocept Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pezolerocept Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Pezolerocept Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pezolerocept Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pezolerocept Sales Market Share by Country/Region (2025)
Figure 10. Pezolerocept Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 450 mg/7.5 mL
Figure 12. Product Picture of 150 mg/mL
Figure 13. Global Pezolerocept Sales Market Share by Type in 2026
Figure 14. Global Pezolerocept Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Intravenous Infusion
Figure 16. Product Picture of Subcutaneous Injection
Figure 17. Global Pezolerocept Sales Market Share by Route of Administration in 2026
Figure 18. Global Pezolerocept Revenue Market Share by Route of Administration (2021-2026)
Figure 19. Product Picture of Combined With Conventional Immunosuppressive Agents
Figure 20. Product Picture of Combined With Topical Glucocorticoids
Figure 21. Global Pezolerocept Sales Market Share by Combination Therapy in 2026
Figure 22. Global Pezolerocept Revenue Market Share by Combination Therapy (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Pezolerocept Sales Market Share by Sales Channels in 2026
Figure 27. Global Pezolerocept Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Pezolerocept Consumed in Treatment Of Generalized Pustular Psoriasis
Figure 29. Global Pezolerocept Market: Treatment Of Generalized Pustular Psoriasis (2021-2026) & (Units)
Figure 30. Pezolerocept Consumed in Treatment Of Palmoplantar Pustulosis
Figure 31. Global Pezolerocept Market: Treatment Of Palmoplantar Pustulosis (2021-2026) & (Units)
Figure 32. Pezolerocept Consumed in Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases
Figure 33. Global Pezolerocept Market: Treatment Of IL-36 Mediated Autoinflammatory Skin Diseases (2021-2026) & (Units)
Figure 34. Pezolerocept Consumed in Others
Figure 35. Global Pezolerocept Market: Others (2021-2026) & (Units)
Figure 36. Global Pezolerocept Sale Market Share by Application (2025)
Figure 37. Global Pezolerocept Revenue Market Share by Application in 2025
Figure 38. Pezolerocept Sales by Company in 2025 (Units)
Figure 39. Global Pezolerocept Sales Market Share by Company in 2025
Figure 40. Pezolerocept Revenue by Company in 2025 ($ millions)
Figure 41. Global Pezolerocept Revenue Market Share by Company in 2025
Figure 42. Global Pezolerocept Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Pezolerocept Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Pezolerocept Sales 2021-2026 (Units)
Figure 45. Americas Pezolerocept Revenue 2021-2026 ($ millions)
Figure 46. APAC Pezolerocept Sales 2021-2026 (Units)
Figure 47. APAC Pezolerocept Revenue 2021-2026 ($ millions)
Figure 48. Europe Pezolerocept Sales 2021-2026 (Units)
Figure 49. Europe Pezolerocept Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Pezolerocept Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Pezolerocept Revenue 2021-2026 ($ millions)
Figure 52. Americas Pezolerocept Sales Market Share by Country in 2025
Figure 53. Americas Pezolerocept Revenue Market Share by Country (2021-2026)
Figure 54. Americas Pezolerocept Sales Market Share by Type (2021-2026)
Figure 55. Americas Pezolerocept Sales Market Share by Application (2021-2026)
Figure 56. United States Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Pezolerocept Sales Market Share by Region in 2025
Figure 61. APAC Pezolerocept Revenue Market Share by Region (2021-2026)
Figure 62. APAC Pezolerocept Sales Market Share by Type (2021-2026)
Figure 63. APAC Pezolerocept Sales Market Share by Application (2021-2026)
Figure 64. China Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 68. India Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Pezolerocept Sales Market Share by Country in 2025
Figure 72. Europe Pezolerocept Revenue Market Share by Country (2021-2026)
Figure 73. Europe Pezolerocept Sales Market Share by Type (2021-2026)
Figure 74. Europe Pezolerocept Sales Market Share by Application (2021-2026)
Figure 75. Germany Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 76. France Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Pezolerocept Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Pezolerocept Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Pezolerocept Sales Market Share by Application (2021-2026)
Figure 83. Egypt Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Pezolerocept Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Pezolerocept in 2026
Figure 89. Manufacturing Process Analysis of Pezolerocept
Figure 90. Industry Chain Structure of Pezolerocept
Figure 91. Channels of Distribution
Figure 92. Global Pezolerocept Sales Market Forecast by Region (2027-2032)
Figure 93. Global Pezolerocept Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Pezolerocept Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Pezolerocept Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Pezolerocept Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Pezolerocept Revenue Market Share Forecast by Application (2027-2032)
